138 related articles for article (PubMed ID: 22206629)
1. The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease.
Pochini L; Scalise M; Galluccio M; Pani G; Siminovitch KA; Indiveri C
Biochim Biophys Acta; 2012 Mar; 1818(3):559-65. PubMed ID: 22206629
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution in liposomes of the functionally active human OCTN1 (SLC22A4) transporter overexpressed in Escherichia coli.
Pochini L; Scalise M; Galluccio M; Amelio L; Indiveri C
Biochem J; 2011 Oct; 439(2):227-33. PubMed ID: 21726197
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter.
Pochini L; Scalise M; Di Silvestre S; Belviso S; Pandolfi A; Arduini A; Bonomini M; Indiveri C
Biochim Biophys Acta; 2016 Apr; 1858(4):653-60. PubMed ID: 26724204
[TBL] [Abstract][Full Text] [Related]
4. Immuno-detection of OCTN1 (SLC22A4) in HeLa cells and characterization of transport function.
Pochini L; Scalise M; Indiveri C
Int Immunopharmacol; 2015 Nov; 29(1):21-6. PubMed ID: 25937167
[TBL] [Abstract][Full Text] [Related]
5. Epitope shared by functional variant of organic cation/carnitine transporter, OCTN1, Campylobacter jejuni and Mycobacterium paratuberculosis may underlie susceptibility to Crohn's disease at 5q31.
Lamhonwah AM; Ackerley C; Onizuka R; Tilups A; Lamhonwah D; Chung C; Tao KS; Tellier R; Tein I
Biochem Biophys Res Commun; 2005 Dec; 337(4):1165-75. PubMed ID: 16246312
[TBL] [Abstract][Full Text] [Related]
6. Regulation by physiological cations of acetylcholine transport mediated by human OCTN1 (SLC22A4). Implications in the non-neuronal cholinergic system.
Pochini L; Scalise M; Galluccio M; Indiveri C
Life Sci; 2012 Nov; 91(21-22):1013-6. PubMed ID: 22569296
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional analysis of intestinal organic cation/L-carnitine transporter (OCTN) in Crohn's disease.
Girardin M; Dionne S; Goyette P; Rioux J; Bitton A; Elimrani I; Charlebois P; Qureshi I; Levy E; Seidman EG
J Crohns Colitis; 2012 Mar; 6(2):189-97. PubMed ID: 22325173
[TBL] [Abstract][Full Text] [Related]
8. Wide tolerance to amino acids substitutions in the OCTN1 ergothioneine transporter.
Frigeni M; Iacobazzi F; Yin X; Longo N
Biochim Biophys Acta; 2016 Jun; 1860(6):1334-42. PubMed ID: 26994919
[TBL] [Abstract][Full Text] [Related]
9. Effect of Cholesterol on the Organic Cation Transporter OCTN1 (SLC22A4).
Pochini L; Pappacoda G; Galluccio M; Pastore F; Scalise M; Indiveri C
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041338
[TBL] [Abstract][Full Text] [Related]
10. Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4).
Urban TJ; Yang C; Lagpacan LL; Brown C; Castro RA; Taylor TR; Huang CC; Stryke D; Johns SJ; Kawamoto M; Carlson EJ; Ferrin TE; Burchard EG; Giacomini KM
Pharmacogenet Genomics; 2007 Sep; 17(9):773-82. PubMed ID: 17700366
[TBL] [Abstract][Full Text] [Related]
11. Functional and molecular effects of mercury compounds on the human OCTN1 cation transporter: C50 and C136 are the targets for potent inhibition.
Galluccio M; Pochini L; Peta V; Iannì M; Scalise M; Indiveri C
Toxicol Sci; 2015 Mar; 144(1):105-13. PubMed ID: 25490951
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
13. Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa.
Kobayashi D; Tamai I; Sai Y; Yoshida K; Wakayama T; Kido Y; Nezu J; Iseki S; Tsuji A
Reproduction; 2007 Nov; 134(5):651-8. PubMed ID: 17965255
[TBL] [Abstract][Full Text] [Related]
14. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.
Yabuuchi H; Tamai I; Nezu J; Sakamoto K; Oku A; Shimane M; Sai Y; Tsuji A
J Pharmacol Exp Ther; 1999 May; 289(2):768-73. PubMed ID: 10215651
[TBL] [Abstract][Full Text] [Related]
15. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
Noble CL; Nimmo ER; Drummond H; Ho GT; Tenesa A; Smith L; Anderson N; Arnott ID; Satsangi J
Gastroenterology; 2005 Dec; 129(6):1854-64. PubMed ID: 16344054
[TBL] [Abstract][Full Text] [Related]
16. Functional role of the 503F variant of the organic cation transporter OCTN1 in Crohn's disease.
Taubert D; Grimberg G; Jung N; Rubbert A; Schömig E
Gut; 2005 Oct; 54(10):1505-6. PubMed ID: 16162962
[No Abstract] [Full Text] [Related]
17. OCTN1 (SLC22A4) displays two different transport pathways for organic cations or zwitterions.
Pochini L; Barone F; Console L; Brunocilla C; Galluccio M; Scalise M; Indiveri C
Biochim Biophys Acta Biomembr; 2024 Feb; 1866(2):184263. PubMed ID: 38092232
[TBL] [Abstract][Full Text] [Related]
18. Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1.
Kato Y; Kubo Y; Iwata D; Kato S; Sudo T; Sugiura T; Kagaya T; Wakayama T; Hirayama A; Sugimoto M; Sugihara K; Kaneko S; Soga T; Asano M; Tomita M; Matsui T; Wada M; Tsuji A
Pharm Res; 2010 May; 27(5):832-40. PubMed ID: 20224991
[TBL] [Abstract][Full Text] [Related]
19. L503F variant of carnitine/organic cation transporter 1 efficiently transports metformin and other biguanides.
Futatsugi A; Masuo Y; Kawabata S; Nakamichi N; Kato Y
J Pharm Pharmacol; 2016 Sep; 68(9):1160-9. PubMed ID: 27350110
[TBL] [Abstract][Full Text] [Related]
20. Increased ergothioneine tissue concentrations in carriers of the Crohn's disease risk-associated 503F variant of the organic cation transporter OCTN1.
Taubert D; Jung N; Goeser T; Schömig E
Gut; 2009 Feb; 58(2):312-4. PubMed ID: 19136526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
